Procept BioRobotics (Nasdaq:PRCT) announced that it received FDA investigational device exemption (IDE) for a second ...
Company also announces 510(k) pending for LigaSure™ RAS Maryland instrument on the Hugo RAS system, and 510(k) clearance for ProGrip™ Advanced self-gripping polypropylene mesh for use in ...
EndoQuest will commence its PARADIGM clinical trial for endoluminal robotic colorectal surgery at five leading US hospitals in early 2025 Houston, TX, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The US Food and ...
First procedures completed and enrollment underway in Embrace Gynecology study, furthering the company's progress to expand minimally invasive treatment options to patients in the United States GALWAY ...
Company prepares to support clinical trial in the United States NEW BRUNSWICK, N.J., Nov. 12, 2024 /PRNewswire/ -- Johnson & Johnson MedTech, a global leader in cardiovascular, orthopaedic, surgery ...
Microbot Medical Inc. MBOT recently announced that it has filed an Investigation Device Exemption (IDE) application with the FDA. The FDA's clearance of the IDE application would enable the business ...
JACKSONVILLE, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients ...
Home » MMI gets IDE for robotic microsurgical study in Alzheimer’s To read the full story, subscribe or sign in.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results